Agilent | A - Bienes





Bienes Cambio Fecha
Abbott USD 110.43B 23.72B 2026-03
Agilent USD 12.81B 86M 2025-12
Align Technology USD 6.31B 80.48M 2026-03
Bio Techne USD 2.52B 3.45M 2025-12
Bio-Rad Laboratories USD 9.79B 786.5M 2026-03
Bruker USD 6.24B 193.5M 2025-12
Charles River Laboratories USD 7.14B 378.39M 2025-12
Danaher USD 83.54B 80M 2026-03
Dentsply International USD 5.23B 200M 2026-03
Edwards Lifesciences USD 13.7B 425M 2025-12
Henry Schein USD 11.3B 89M 2026-03
Illumina USD 6.56B 85M 2026-03
Intuitive Surgical USD 20.11B 347.7M 2026-03
IQVIA Holdings USD 29.68B 269M 2026-03
Laboratory Of America USD 19.09B 694.4M 2026-03
Mettler Toledo International USD 3.71B 191.18M 2025-12
Myriad Genetics USD 673.7M 32.9M 2026-03
OraSure Technologies USD 403.17M 19.93M 2025-12
Quest Diagnostics USD 16.67B 448M 2026-03
Quidel USD 5.63B 140.6M 2026-03
Repligen USD 2.95B 25.99M 2025-12
Revvity USD 12.17B 29.46M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12
Thermo Fisher Scientific USD 113.28B 2.94B 2026-03
Waters USD 24.53B 19.45B 2026-03
Zimmer Biomet Holdings USD 22.72B 370.1M 2026-03